Abstract
The evidence that genetic factors are involved in risk and outcome of pneumonia is clear. Most likely genetic factors play a role in risk of VAP in a subgroup of patients as well. In the past years, a large number of polymorphisms in diverse inflammatory genes have been identified as candidates to explain genetic variability in susceptibility to pulmonary infections and its adverse outcomes. Despite the number of variations already discovered, the clinical implications remain unclear. The need to advance from simple statistical significance to biological understanding is clear. Future welldesigned studies will need to address the extremely complex gene-gene and gene-environment interactions, particularly in ventilator-associated pneumonia. Large collaborative efforts creating exquisitely detailed (both clinically and microbiologically) cohorts are required to establish this rigorous approach and produce replicable results. Complementary translational studies of the functionality of the genetic variations identified are needed. Despite the criticisms raised, early examples of pharmacogenetics aspects of infectious diseases have been shown. Hopefully this renewed approach will take a step further in accomplishing the enormous promise of genetics and personalized medicine.
Keywords: Ventilator-associated pneumonia, sepsis, polymorphisms, genetic risk
Current Respiratory Medicine Reviews
Title: Association of Genetic Variation with Pneumonia
Volume: 6 Issue: 1
Author(s): Anke H.W. Bruns and R. G. Wunderink
Affiliation:
Keywords: Ventilator-associated pneumonia, sepsis, polymorphisms, genetic risk
Abstract: The evidence that genetic factors are involved in risk and outcome of pneumonia is clear. Most likely genetic factors play a role in risk of VAP in a subgroup of patients as well. In the past years, a large number of polymorphisms in diverse inflammatory genes have been identified as candidates to explain genetic variability in susceptibility to pulmonary infections and its adverse outcomes. Despite the number of variations already discovered, the clinical implications remain unclear. The need to advance from simple statistical significance to biological understanding is clear. Future welldesigned studies will need to address the extremely complex gene-gene and gene-environment interactions, particularly in ventilator-associated pneumonia. Large collaborative efforts creating exquisitely detailed (both clinically and microbiologically) cohorts are required to establish this rigorous approach and produce replicable results. Complementary translational studies of the functionality of the genetic variations identified are needed. Despite the criticisms raised, early examples of pharmacogenetics aspects of infectious diseases have been shown. Hopefully this renewed approach will take a step further in accomplishing the enormous promise of genetics and personalized medicine.
Export Options
About this article
Cite this article as:
Bruns H.W. Anke and Wunderink G. R., Association of Genetic Variation with Pneumonia, Current Respiratory Medicine Reviews 2010; 6 (1) . https://dx.doi.org/10.2174/157339810790820377
DOI https://dx.doi.org/10.2174/157339810790820377 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Inflammatory Events Following Subarachnoid Hemorrhage (SAH)
Current Neuropharmacology The Application of X-ray, NMR, and Molecular Modeling in the Design of MMP Inhibitors
Current Topics in Medicinal Chemistry Chemistry and Pharmacology of Natural Catechins from <i>Camellia sinensis</i> as Anti-MRSA Agents
Current Topics in Medicinal Chemistry Caring for HIV-Infected Patients in the ICU in The Highly Active Antiretroviral Therapy Era
Current HIV Research Post Traumatic Lesion absence of β-Dystroglycan-Immunopositivity in Brain Vessels Coincides with the Glial Reaction and the Immunoreactivity of Vascular Laminin
Current Neurovascular Research Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, α -Synuclein Synthesis, Interleukin-1β Release, and Cholinergic Action.
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Migraine, Neurogenic Inflammation, Drug Development - Pharmacochemical Aspects
Current Medicinal Chemistry CSF Ubiquitin As a Specific Biomarker in Alzheimer's Disease
Current Alzheimer Research Immunopathology of Brucella Infection
Recent Patents on Anti-Infective Drug Discovery Severe Meningococcal Infections in Children and Adolescents
Current Pediatric Reviews Targeting the Nucleus: An Overview of Auger-Electron Radionuclide Therapy
Current Drug Discovery Technologies Lysosomal Storage Diseases and the Blood-Brain Barrier
Current Pharmaceutical Design Targeting Nitrosative Stress for Neurovascular Protection: New Implications in Brain Diseases
Current Drug Targets Aquaporins and Glia
Current Neuropharmacology Prokaryotic Substrate-Binding Proteins as Targets for Antimicrobial Therapies
Current Drug Targets Withdrawal Notice: MMR Vaccine Susceptibility of Viral Agents Causing Meningitis and Meningoencephalitis in Children
Infectious Disorders - Drug Targets Extracellular Enzymes Production and Biofilm Formation in Rhodotorula Species
Current Enzyme Inhibition Arterial Ischemic Stroke in Neonates and Children: Review and Current Issues
Current Pediatric Reviews Disease Modifying Approaches for Alzheimers Pathology
Current Pharmaceutical Design B7-H3-targeted Radioimmunotherapy of Human Cancer
Current Medicinal Chemistry